CONMED | CNMD - Equity Capital And Reserves


CONMED reported $1.04B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
3M USD 2.95B 311M Jun/2026
Abbott USD 52.06B 69M Mar/2026
Accuray USD 53.42M 8.45M Dec/2025
AtriCure USD 516.43M 24.74M Jun/2026
Baxter International USD 6.21B 163M Jun/2026
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Boston Scientific USD 24.93B 934M Jun/2026
CONMED USD 1.04B 23.72M Jun/2026
Cooper Companies USD 8.36B 124.7M Dec/2025
Dexcom USD 2.62B 335.5M Jun/2026
Edwards Lifesciences USD 10.62B 290.5M Jun/2026
Globus Medical USD 4.73B 159.06M Mar/2026
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.42B 119.6M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
Intuitive Surgical USD 18.17B 693.9M Jun/2026
J&J USD 84.97B 3.78B Jun/2026
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.68B 53.08M Jun/2026
Olympus JPY 812.04B 38.69B Mar/2026
Orthofix International USD 429.18M 6.01M Jun/2026
ResMed USD 6.49B 171.03M Mar/2026
Smith & Nephew USD 5.18B 356M Jun/2026
Steris USD 7.18B 29.1M Mar/2026
Stryker USD 22.98B 559M Mar/2026
Tandem Diabetes Care USD 132.4M 22.77M Mar/2026
Teleflex USD 3.08B 40.33M Mar/2026
Zimmer Biomet Holdings USD 12.63B 49.1M Jun/2026